Suscribirse

Efficacy and Incontinence Rates After Urethroplasty for Radiation-induced Urethral Stenosis: A Systematic Review and Meta-analysis - 08/06/21

Doi : 10.1016/j.urology.2021.02.014 
Lucas Gomes Sapienza 1, , ⁎⁎ , Matthew Stephen Ning 2, Emanuel de Freitas Carvalho 3, Daniel Spratt 4, Vinícius Fernando Calsavara 5, Patrick W. McLaughlin 4, Maria Jose Leite Gomes 6, Glauco Baiocchi 7, Eyad Abu-Isa 4
1 Department of Radiation Oncology, Baylor College of Medicine, Houston, TX 
2 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 
3 Department of Urology, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil 
4 Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 
5 Department of Statistics and Epidemiology, AC Camargo Cancer Center, São Paulo, SP, Brazil. 
6 Department of Radiation Oncology, Hospital Federal dos Servidores do Estado (HFSE-RJ), Rio de Janeiro, RJ, Brazil 
7 Department of Gynecologic Oncology, A.C. Camargo Cancer Center, São Paulo, SP, Brazil 

Address correspondence to: Lucas G. Sapienza M.D., Ph.D., Radiation Oncology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030.Radiation OncologyBaylor College of Medicine1 Baylor PlazaHoustonTX77030

ABSTRACT

Objective

To estimate the efficacy of urethroplasty and rates of de novo stress urinary incontinence (SUI) in the specific setting of radiation-induced urethral stenosis.

Methods

A systematic search of databases (PubMed and EMBASE) was performed between 1980-2019 (CRD42020144845). Inclusion criteria were: (1) prior pelvic radiotherapy; (2) surgical urethroplasty; (3) rates of successful treatment and/or SUI development and (4) total case number provided. The pooled summary of stenosis resolution rate and SUI were calculated using the random-effects model weighted by the inverse variance. Accessory analyses were performed by reconstructive technique and type of RT.

Results

Ninety-six studies were identified, of which 8 retrospective studies met inclusion criteria, comprising 256 patients. The proportion of cases treated with external beam RT (EBRT), brachytherapy (BT), or combination (EBRT+BT) were 52%, 33%, and 15%, respectively, of studies that specified modality. Most strictures involved the bulbomembranous region (n = 212; 83%). Sixty-one percent of cases (n = 157) entailed primary anastomosis, while the remainder underwent augmentation reconstruction (graft or flap). The mean follow-up time after urethroplasty varied from 10 to 50.5 months. The pooled stenosis resolution rate was 80% (95% CI: 74%-86%). There were no significant associations between stenosis resolution rate and reconstructive technique (rho=0.20, P = .74) or RT modality (rho=-0.31, P = .53). Fifty-three cases developed subsequent SUI, with a pooled complication rate of 19% (95% CI: 10%-31%).

Conclusions

Urethroplasty after radiation-induced urethral stenosis is effective for 80% of cases, independent of prior RT modality or urethroplasty technique; however, 1 out of every 5 patients develops SUI post-procedure.

El texto completo de este artículo está disponible en PDF.

Esquema


 Competing interests: The authors have nothing to disclose.
 Acknowledgments: none.
 Financial Support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
 Note: This report was presented at the 62nd Meeting of the American Society for Radiation Oncology, Virtual Meeting, October 24-28, 2020.


© 2021  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 152

P. 109-116 - juin 2021 Regresar al número
Artículo precedente Artículo precedente
  • AUTHOR REPLY
  • Jonathan N. Warner
| Artículo siguiente Artículo siguiente
  • EDITORIAL COMMENTS
  • Alex Nourian, Dmitriy Nikolavsky, Jay Simhan

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.